Ep174: Najat Khan on the TechBio Movement
Podcast: The Long Run with Luke TimmermanPublished On: Mon Mar 03 2025
Description: Najat Khan, chief R&D and chief commercial officer of Recursion, on using technology to improve drug discovery.
The note was deleted
The note was saved
Your message was sent